Cultivate Biologics Logo

About Us

Who We Are

Cultivate Biologics stands at the forefront of cannabinoid research, dedicated to unlocking the therapeutic potential of the hemp plant for both human and animal health. With an integrated approach, we manage the entire supply chain—from the genetics of proprietary hemp cultivars to formulation and manufacturing—ensuring the highest standards of quality and consistency.

Our commitment to scientific excellence is exemplified through extensive clinical research, forging collaborations with esteemed academic institutions, and advancing botanical drug development. With a focus on full-spectrum cannabinoid extracts, we lead the charge in developing innovative and effective therapies.

At Cultivate Biologics, our mission is clear: to cultivate wellness through nature’s precision. Join us in this transformative journey as we redefine possibilities in health and well-being.

Who We Are

We at Cultivate are scientists and researchers, plant geneticists and business leaders. To be the best for our customers we need expertise in all areas of the camabinoid business, not just growing the best plants. Cultivate employees are known in their respective fields for being the best and when you bring the best together, great things happen. We have partnerships and studies ongoing with leading research institutions, such as Johns Hopkins Medical, Oregon State University, and Washington State University. We are committed to using knowledge to expand the possibilities in cannabinoid products and to change the conversation about cannabinoids. Our goal is to make cannabinoid products for our customers that are so good, they will change the industry for the better.

Our Infrastructure

Cultivate upholds unwavering standards of quality and precision in our formulations and product development. Our commitment to excellence is fortified by a robust infrastructure that includes cutting-edge in-house analytical capabilities, strategic partnerships with top-tier third-party testing providers, and meticulous quality control protocols aligned with GMP 21 CFR 111 and 117 standards for food and supplements.

With the aid of advanced High-Performance Liquid Chromatography (HPLC) and Gas Chromatography (GC) systems, we ensure rapid and comprehensive testing of every production batch, assessing cannabinoids and terpenes with precision in a matter of hours.

Cultivate upholds unwavering standards of quality and precision in our formulations and product development. Our commitment to excellence is fortified by a robust infrastructure that includes cutting-edge in-house analytical capabilities, strategic partnerships with top-tier third-party testing providers, and meticulous quality control protocols aligned with GMP 21 CFR 111 and 117 standards for food and supplements.

With the aid of advanced High-Performance Liquid Chromatography (HPLC) and Gas Chromatography (GC) systems, we ensure rapid and comprehensive testing of every production batch, assessing cannabinoids and terpenes with precision in a matter of hours.

Our proficiency extends beyond product quality to navigating the complexities of the FDA’s IRB and IND processes for academic research. At Cultivate, we are committed to supporting your research endeavors, leveraging our expertise to facilitate a seamless and compliant journey through regulatory requirements.

Our Infrastructure

Cultivate maintains the highest standards of quality and consistency in our formulations and product development due to our in-house analytical capabilities, exceptional third party testing partners, combined with our quality control protocols that meet GMP 21 CFR 111 And 117 standards for food and supplements. We are able to test every batch of oil we produce in a matter of hours for both cannabinoids and terpenes with our High Performance Liquid Chromatography (HPLC) and Gas Chromatography (GC) systems. 

Founded on a Love of Science and a Passion to Improve Human and Animal Health

Christian Kjaer

Christian Kjaer

Board Chair & CEO

Christian Kjaer, Board Chair & CEO, brings a wealth of executive experience to Cultivate Biologics. A former senior executive at IDEXX Laboratories, Christian served as President of OPTI Medical Systems and held the positions of VP and GM of the Water Division, as well as VP and GM of the South Asia/Middle East/Africa Region. His extensive leadership extends beyond borders, as he has previously held CEO positions in prominent European tech companies.

In addition to his role at Cultivate Biologics, Christian serves as the Board Chair and CEO of ElleVet Sciences and TevElle Pharmaceuticals. He holds a Master of Business from the prestigious Copenhagen Business School, a testament to his academic dedication and business acumen. Christian’s multifaceted expertise and strategic vision guide Cultivate Biologics towards a future of innovative and impactful advancements in the field of cannabinoid research.

 

Joseph Wakshlag

Dr. Joseph Wakshlag, DVM, PhD, DACVN, DACVSMR

Chief Scientific Officer

Dr. Joseph Wakshlag, DVM, PhD, DACVN, DACVSMR, serves as the Chief Scientific Officer at Cultivate Biologics. Currently a distinguished professor at the Cornell College of Veterinary Medicine, he also holds the pivotal role of Chief Veterinary Medical Officer at ElleVet Sciences, a renowned leader in veterinary hemp products. With a rich background, Dr. Wakshlag is a charter member of the American College of Sports Medicine and Rehabilitation, highlighting his dedication to the interdisciplinary field of sports medicine.

His significant contributions to the scientific community include authoring 14 publications, encompassing a diverse range of topics in full spectrum CBD/CBDA hemp use. Dr. Wakshlag has conducted pioneering clinical trials examining the efficacy of hemp in conditions such as osteoarthritis, acute post-surgical pain, and atopic dermatitis in dogs. His research extends beyond species boundaries, delving into cross-species pharmacokinetics in horses, cats, dogs, and birds.

Dr. Wakshlag’s multifaceted expertise positions him as a key figure in advancing the understanding of cannabinoid therapeutics, contributing to the growth and success of Cultivate Biologics in the realm of innovative health solutions.

Christian Kjaer

Christian Kjaer

Board Chair & CEO

Former senior executive at IDEXX Laboratories: President of OPTI Medical Systems; VP and GM of Water Division; VP and GM of South Asia/Middle East/Africa Region. Former CEO of European tech companies. Christian is also Board Chair and CEO of ElleVet Sciences and TevElle Pharmaceuticals and holds a Master of Business from Copenhagen Business School.